NEW YORK, March 31, 2020 /PRNewswire/ --
- tellic graph.C19 visualizes 12 million connections between
COVID-19 and related genes, drugs, phenotypes and variants
- Scientists at Empire Discovery Institute are using graph.C19 to
surface insights spanning two million publications as part of
New York State's COVID-19
response
- COVID-19 researchers are invited to register at
https://info.tellic.com/tellic-graph.covid-19-registration
tellic, a technology startup based in New York, NY has been working for five years
to develop an AI tool that surfaces actionable insights from
biomedical research. Numerous biopharma currently use tellic graph
as an AI-powered literature review tool to expedite their
research.
Today, tellic is announcing a graph.C19 version of its product
containing data on COVID-19 and other coronaviruses to researchers
at biopharma, academic institutions and non-profits. This
web-accessible tool comprises over 12 million distinct connections
across two million unique documents. It enables any researcher to
log in and instantly access integrated knowledge from previous
experience with coronaviruses, including SARS and MERS, as well as
gain insights from the growing sea of biomedical data on
COVID-19.
Empire Discovery Institute contacted tellic last week to ask to
use tellic graph to help their Scientific Advisory Board move
faster to identify insights in COVID-19 research. "tellic graph.c19
enables our researchers to surface insights from millions of
research articles in minutes. This process can take years with
traditional methods," says Martin
Graham, CEO of Empire Discovery Institute.
The release of tellic graph.C19 is a direct response to the
White House call to action, which was made in partnership with the
Allen Institute for AI, Chan Zuckerberg Initiative, Georgetown University's Center for Security and
Emerging Technology, Microsoft, and the National Library of
Medicine at the National Institutes of Health, requesting the AI
community create technologies using natural language processing-a
core technology used in tellic graph. This tool allows researchers
to query key high-priority questions related to COVID-19, and
connect the dots between findings in millions of data sources,
addressing the White House's call to action.
"Last year, we launched the first biopharma knowledge graph that
enables scientists to instantly connect the dots on insights
scattered across tens of millions of documents," says Richard Wendell, tellic Founder and CEO. "Today
we are giving scientists a version containing all internetworked
knowledge on COVID-19 because we want to do our part to fight back
against this pandemic."
Starting today, licenses will be made available on a rolling
basis for three months, up to three per organization. tellic will
lead a blog forum for registered researchers to share findings and
research questions. Researchers working on COVID-19 are invited to
register at
https://info.tellic.com/tellic-graph.covid-19-registration
About tellic: The company was founded in 2015 by
Richard Wendell, a Fortune 500 Chief
Data Officer, whose vision was to make it easy for pharma companies
to apply emerging data science technologies to their pipelines.
tellic pioneers a new category of enterprise-scale biomedical
language processing and knowledge discovery powered by machine
learning. For more information, please
contact info@tellic.com
About tellic graph: tellic graph uses natural
language processing and AI technologies to expedite literature
search. Researchers can save hours of cycles of manual search
strategies in PubMed and other sources, and directly surface a list
of the most relevant connections and sources supporting those
connections for easy manual review. This tool can uncover
unexpected connections as it searches across millions of biomedical
data sources.
About tellic graph.C19: tellic graph.C19 provides
data-supported relationships between COVID-19, other coronaviruses
and biomedical entities including genes, variants, phenotypes and
drugs.
Video overview of tellic graph:
https://www.youtube.com/watch?v=oMDtyx1xukA&feature=youtu.be
Media contact:
Irene Kaganman
info@tellic.com
(212) 221-8612
View original content to download
multimedia:http://www.prnewswire.com/news-releases/tellic-gives-scientists-free-access-to-ai-tool-that-accelerates-covid-19-research-301032813.html
SOURCE tellic